[
  {
    "objectID": "publications.html",
    "href": "publications.html",
    "title": "Publications",
    "section": "",
    "text": "Ehrhardt H, Lambe J, Moussa H, Vasileiou, Kalaitzidis G, Murphy OC, et al. Effects of ibudilast on retinal atrophy in progressive multiple sclerosis subtypes: post-hoc analyses of the SPRINT-MS Trial. Neurology. 2023; 101(10):e1014-1024. doi: 10.1212/WNL.0000000000207551.\nKalaitzidis G, Pellegrini N, Nagy N, Vasileiou E, Ehrhardt H, Reppen A,… Lambe J, et al. Effects of myopia on rates of change in optical coherence tomography measured retinal layer thicknesses in people with multiple sclerosis and healthy controls. Curr Eye Res. 2023; 48(3):312-319. doi: 10.1080/02713683.2022.2149806.\nMurphy OC, Sotirchos ES, Kalaitzidis G, Vasileiou E, Ehrhardt H, Lambe J, Kwakyi O, et al. Trans-synaptic degeneration following acute optic neuritis in multiple sclerosis. Ann Neurol. 2023; 93(1):76-87. doi: 10.1002/ana.26529.\nKalaitzidis G, Filippatou AG, Fioravante F, Rothman A, Sotirchos ES, Vasileiou ES,… Lambe J, et al. Visual pathway involvement in NMDA receptor encephalitis: a clinical, optical coherence tomography, and 18-fluorodeoxyglucose PET/CT approach. J Neuroophthalmol. 2023; 43(2):220-226. doi: 10.1097/WNO.0000000000001696.\nLambe J, McGinley MP, Moss BP, Mao-Draayer Y, Kassa R, Ciotti J, et al. Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series. J Neuroimmunol. 2022; 370:577933. doi: 10.1016/j.jneuroim.2022.577933.\nSotirchos ES, Vasileiou ES, Filippatou AG, Fitzgerald KC, Smith MD, Lord HN, Kalaitzidis G, Lambe J, et al. Association of serum neurofilament light chain with inner retinal layer thinning in multiple sclerosis. Neurology. 2022; 99(7):e688-e697. doi: 10.1212/WNL.0000000000200778.\nVasileiou ES, Filippatou AF, Pimentel Maldonado D, Kalaitzidis G, Ehrhardt H, Lambe J, et al. Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis. Brain. 2021; 144(12):3665-3673. doi: 10.1093/brain/awab342.\nMizell R, Chen H, Lambe J, Saidha S, Harrison DM. Association of retinal atrophy with cortical lesions and leptomeningeal enhancement in multiple sclerosis on 7T MRI. Mult Scler. 2022; 28(3):393-405. 2021. doi: 10.1177/13524585211023343.\nFilippatou AG, Vasileiou ES, He Y, Fitzgerald KC, Kalaitzidis G, Lambe J, et al. Optic neuritis-independent retinal atrophy in neuromyelitis optica spectrum disorder. J Neuroophthalmol. 2022; 42(1):e40-e47. doi: 10.1097/WNO.0000000000001282.\nLambe J, Risher H, Filippatou AG, Murphy OC, Sotirchos ES, Ehrhardt H, et al. Modulation of retinal atrophy with rituximab in multiple sclerosis. Neurology. 2021; 96(20)e2525-e2533. doi: 10.1212/WNL.0000000000011933.\nLambe J, Fitzgerald KC, Murphy OC, Filippatou AG, Sotirchos ES, Kalaitzidis G, et al. Association of spectral-domain OCT with long-term disability worsening in multiple sclerosis. Neurology. 2021; 96(16):e2058-e2069. doi: 10.1212/WNL.0000000000011788.\nMurphy OC, Kalaitzidis G, Vasileiou E, Filippatou AG, Lambe J, Ehrhardt H, et al. Optical coherence tomography and optical coherence tomography angiography findings after optic neuritis in multiple sclerosis. Front Neurol. 2020; 11:618879. doi: 10.3389/fneur.2020.618879.\nFilippatou AG, Moniruzzaman M, Sotirchos ES, Fitzgerald KC, Kalaitzidis G, Lambe J, et al. Serum ceramide levels are altered in multiple sclerosis. Mult Scler. 2021; 27(10):1506-1519. doi: 10.1177/1352458520971816.\nFilippatou AG, Vasileiou ES, He Y, Fitzgerald KC, Kalaitzidis G, Lambe J, et al. Evidence of subclinical quantitative retinal layer abnormalities in AQP4-IgG seropositive NMOSD. Mult Scler. 2021; 27(11):1738-1748. doi: 10.1177/1352458520977771.\nLambe J, Saidha S, Bermel R. Optical coherence tomography and multiple sclerosis: Update on clinical application and role in clinical trials. Mult Scler. 2020; 26(6):624-639. doi: 10.1177/1352458519872751.\nFilippatou AG, Lambe J, Sotirchos ES, Fitzgerald KC, Aston A, Murphy OC, et al. [*Authors contributed equally]. Association of body mass index with longitudinal rates of retinal atrophy in multiple sclerosis. Mult Scler. 2020; 26(7):843-854. doi: 10.1177/1352458519900942.\nSotirchos ES, Gonzalez-Caldito N, Filippatou AG, Fitzgerald KC, Murphy OC, Lambe J, et al. Progressive multiple sclerosis is associated with faster and specific retinal layer atrophy. Ann Neurol. 2020; 87(6):885-896. doi: 10.1002/ana.25738.\nLambe J, Rothman A, Prince J, Saidha S, Calabresi PA, Newsome SD. Retinal pathology occurs in stiff person syndrome. Neurology. 2020; 94(20):e2126-e2131. doi: 10.1212/WNL.0000000000008943.\nLambe J, Murphy OC, Mu W, Sondergaard Schatz K, Baranano K, Venkatesan A. Relapsing remitting clinical course expands the phenotype of Aicardi-Goutières syndrome. Ann Clin Transl Neurol. 2020; 7(2):254-258. doi: 10.1002/acn3.50979.\nMurphy OC, Kwakyi O, Iftikhar M, Zafar S, Lambe J, Pellegrini N, et al. Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures. Mult Scler. 2020; 26(7): 815-828. doi: 10.1177/1352458519845116.\nBede P, Finegan E, Chipika RH, Shing SL, Lambe J, Meaney J, Redmond J. Occulomotor neural integrator dysfunction in multiple sclerosis: insights from neuroimaging. Front Neurol. 2018; 23;9:691. doi: 10.3389/fneur.2018.00691.\nLambe J, Monaghan B, Munteanu T, Redmond J. CAPN1 mutations broadening the hereditary spastic paraplegia/spinocerebellar ataxia phenotype. Pract Neurol. 2018; 18(5):369-372. doi: 10.1136/practneurol-2017-001842.\nLambe J, Murphy OC, Saidha S. Can optical coherence tomography be used to guide treatment decisions in adult or pediatric multiple sclerosis? Curr Treat Options Neurol. 2018; 20(4):9. doi: 10.1007/s11940-018-0493-6.\nLambe J, Noone I, Lonergan R, Tubridy N. Auditing the frequency and the clinical and economic impact of testing for Fabry disease in patients under the age of 70 with a stroke admitted to Saint Vincent’s University Hospital over a 6-month period. Ir J Med Sci. 2018; 187(1):189-92. doi: 10.1007/s11845-017-1625-9.\nLambe J, Redmond J. Analysis of the outpatient lumbar puncture service in a tertiary hospital. Ir J Med Sci. 2018; 187(2):521-524. Doi: 10.1007/s11845-017-1681-1.\n\n\nView the tutorial for this template (+ download link)"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Jeff Lambe",
    "section": "",
    "text": "Twitter\n  \n  \n    \n     Email\n  \n\n\n\n\nWelcome to my website!\nMy name is Jeff Lambe. I am an Irish neuroimmunology fellow at the Cleveland Clinic. I am currently studying for a masters degree in clinical research through Case Western Reserve University. My primary research interest is in the development and validation of imaging biomarkers of neurodegeneration and remyelination in multiple sclerosis."
  },
  {
    "objectID": "cv.html",
    "href": "cv.html",
    "title": "Curriculum vitae",
    "section": "",
    "text": "Download current CV\n  \n\n\n  \n\n\nView the tutorial for this template (+ download link)"
  },
  {
    "objectID": "about.html",
    "href": "about.html",
    "title": "About",
    "section": "",
    "text": "About this site\n\n1 + 1\n\n[1] 2"
  },
  {
    "objectID": "education.html",
    "href": "education.html",
    "title": "Education & Training",
    "section": "",
    "text": "2024 - Clinical Research Fellow, Neuroimmunology\nMellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH\n\n\n\n2024 - Candidate, Master’s Degree in Clinical Research\nClinical Research Scholars Program, Case Western Reserve University, Cleveland, OH\n\n\n\n2020 - 2024 - Residency, Adult Neurology\nChief Resident, 2023-24\nCleveland Clinic, Cleveland, OH\n\n\n\n2018 - 2024 - MD (Doctor of Medicine Graduate Research Degree)\nThesis: In vivo investigation of the modulation of retinal atrophy by ocrelizumab in multiple sclerosis: a prospective study\nUniversity College Dublin, Dublin, Ireland\n\n\n\n2018 – 2020 - Post-Doctoral Research Fellowship, Neuroimmunology\nJohns Hopkins School of Medicine, Baltimore, MD\n\n\n\n2018 – 2019 - Statistical Methods in Public Health\nJohns Hopkins Bloomberg School of Public Health, Baltimore, MD\n\n\n\n2016 – 2018 - MRCPI (Member of the Royal College of Physicians of Ireland), Senior House Officer, Internal Medicine\nSaint James’s Hospital, Dublin, Ireland\n\n\n\n2015 – 2016 - Intern, Medicine\nSaint Vincent’s Hospital, Dublin, Ireland\n\n\n\n2009 – 2015 - MBBCh (Bachelor of Medicine, Bachelor of Surgery)\nUniversity College Dublin, Dublin, Ireland\n\nView the tutorial for this template (+ download link)"
  },
  {
    "objectID": "interests.html",
    "href": "interests.html",
    "title": "Education & Training",
    "section": "",
    "text": "2024 - Clinical Research Fellow, Neuroimmunology\nMellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH\n2024 - Candidate, Master’s Degree in Clinical Research\nClinical Research Scholars Program, Case Western Reserve University, Cleveland, OH\n2020 - 2024 - Residency, Adult Neurology\nChief Resident, 2023-24\nCleveland Clinic, Cleveland, OH\n2018 - 2024 - MD (Doctor of Medicine Graduate Research Degree)\nThesis: In vivo investigation of the modulation of retinal atrophy by ocrelizumab in multiple sclerosis: a prospective study\nUniversity College Dublin, Dublin, Ireland\n2018 – 2020 - Post-Doctoral Research Fellowship, Neuroimmunology\nJohns Hopkins School of Medicine, Baltimore, MD\n2018 – 2019 - Statistical Methods in Public Health\nJohns Hopkins Bloomberg School of Public Health, Baltimore, MD\n2016 – 2018 - MRCPI (Member of the Royal College of Physicians of Ireland), Senior House Officer, Internal Medicine\nSaint James’s Hospital, Dublin, Ireland\n2015 – 2016 - Intern, Medicine\nSaint Vincent’s Hospital, Dublin, Ireland\n2009 – 2015 - MBBCh (Bachelor of Medicine, Bachelor of Surgery)\nUniversity College Dublin, Dublin, Ireland\n\nView the tutorial for this template (+ download link)"
  }
]